Wikidata

(Q63403106)

English

A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
main subject
dermatitis
0 references
start time
30 January 2018
0 references
end time
7 February 2019
0 references
number of participants
280
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63403106&oldid=1874425275"